<noscript id="2mmmm"><acronym id="2mmmm"></acronym></noscript>
  • <tt id="2mmmm"></tt>
  • <tt id="2mmmm"><rt id="2mmmm"></rt></tt>
  • <table id="2mmmm"></table>
  • <tt id="2mmmm"><rt id="2mmmm"></rt></tt>
    <tt id="2mmmm"><table id="2mmmm"></table></tt>
    中文
    中文
    為了病患而驅動(dòng)的創(chuàng )新
    Patient-first cell therapy innovation

    科學(xué)論文
    SCIENTIFIC PUBLICATION
    • 04.182025
      2024
      Aberrant cytoplasmic expression of UHRF1 restrains the MHC-I-mediated anti-tumor immune responseNat Commun. 2024 Oct 3;15:8569. doi: 10.1038/s41467-024-52902-5Tan L, Yin T, Xiang H, Wang L, Mudgal P, Chen J, Ding Y, Wang G, Lim BJW, Huang Y, Huang D,
    • 04.162025
      2023
      A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing dataHeliyon. 2023 Oct 5;9(11):e20708. doi: 10.1016/j.heliyon.2023.e20708Du Z, Zhang T, Lin Y, Dong G, Li A, Wang Z, Zhang
    • 06.142022
      2022
      Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy. Cancer Cell 40, 674-693, June 13, 2022 doi:https://doi.org/10.1016/j.ccell.2022.04.018Haixia Long, Qingzhu Jia
    • 03.232022
      2021
      Cancer Cell-Derived GABA Promotes &beta;-Catenin-Mediated Tumor Growth and Immunosuppression.Nat Cell Biol. Author manuscript; available in PMC: 2022 Aug 10.Published in final edited form as: Nat Cell Biol. 2022 Feb 10;24(2):230&ndash;241. do
    • 03.232022
      2020
      Potential lung attack and lethality generated by EpCAM-specific CAR-T cells in immunocompetent mouse models. OncoImmunology 9(1):1806009. (*: Corresponding authors, PMCID: PMC7458607)Qin D., Li D., Zhang B., Chen Y., Liao X., Li X., Alexander P.B., W
    • 03.232022
      2019
      Streamlined Low-Input Transcriptomics through EASY-RNAseq. J Mol Biol. 431(24):5075-5085. (PMID: 31491452)Zhou Y., Xu H., Wu H., Yu H., Zhou P., Qiu X., Zheng Z., Chen Q., Xu F., Li G., Zhou J., Cheng G., He W., Zou L, Wan Y. (2019) TCR repertoi
    12
    查看更多

    Copyright ? 2019 天科雅生物醫藥科技有限公司

    粵公網(wǎng)安備 44011502000528號

    粵ICP備20056630號 Powered by vancheer
    關(guān)于天科雅
    研究與發(fā)展
    產(chǎn)品及臨床
    新聞與媒體
    招賢納士

    Copyright ? 2019 天科雅生物醫藥科技有限公司

    粵公網(wǎng)安備 44011502000528號

    粵ICP備20056630號 Powered by vancheer
    精品无码国产自产在线观看水浒传_西西人体444WwW高清大胆_国产探花在线精品一区二区_成人试看120秒体验区